GYRE THERAPEUTICS INC
GYRE·403783103·US·Common Stock·Healthcare - Biotechnology-Activist
GYRE (GYRE THERAPEUTICS INC) is held by 40 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($6.9M), BlackRock, Inc. ($5.3M), GEODE CAPITAL MANAGEMENT, LLC ($3M). Net institutional sentiment: Mixed.
40
Holders
(2 Elite)
$22.5M
Total Value
65% (34)
Consensus
22 buying - 12 selling
13F: Insider & Congress:
Who's Trading
InsiderYWYe WeiguoSell $24KMay 26, 2026
InsiderYWYe WeiguoSell $21KMay 22, 2026
InsiderYWYe WeiguoSell $87KMay 15, 2026
InsiderYWYe WeiguoSell $108KMay 14, 2026
ActivistSMSongjiang Ma6.3%May 7, 2026
ActivistYLYing Luo8.6%May 6, 2026
InsiderLYLuo YingSell $81KMay 6, 2026
ActivistGUGNI USA, Inc.69.1%May 6, 2026
InsiderLYLuo YingSell $1KMay 5, 2026
InsiderMSMa SongjiangSell $6KMay 28, 2025
Showing 1-20 of 41
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer